Press release license agreement


3. Cautionary note regarding forward-looking statements This release, in addition to historical information, may contain forward-looking statements made pursuant to the Private Securities Litigation Reform Act of 1995. , a gene therapy company advancing transformative therapies for patients with severe medical needs, announced that uniQure and CSL Behring have entered into a licensing agreement providing CSL Behring with exclusive global rights to etranacogene […] Press release: Truly and FlexEnable sign License Agreement to bring low-cost, scalable flexible display production to China 31 July 2017 Cambridge (UK), 31 July 2017 – FlexEnable , the leader in the development and industrialization of organic electronics for flexible displays and sensors, has signed a technology transfer and license Datable previously provided guidance that revenue will grow by over 100% in 2020 with expenses increasing by about 10%, compared to 2019 (see press release dated February 5, 2020). Mar 22, 2017 · REDMOND, Wash. S), the world leader in digital security, today announced a technology and intellectual property license agreement with DAZN, a global leader in digital content distribution. Press Releases – Page is currently under maintenance, please check back later Dais Initiates Strategic Changes for Growth, Enters Into License and Supply Agreement Dec 5, 2019 Press releases. , including, without limitation, statements about: BioMarin’s expectations regarding the announced collaboration, the prospects for the lead and follow on pipeline products and it’s 2020 GAAP profitability. 26 November 2018. It also allows Nestlé to Jun 25, 2020 · ROCKY HILL, Conn. (NASDAQ: PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary diseases, today announced that it has entered into a licensing and development agreement with the Lung Cancer Initiative at Johnson & Johnson*. , foam, enema Leap Therapeutics and BeiGene Announce Exclusive Option and License Agreement for DKN-01 and Leap Announces $27 Million Equity Financing - BeiGene granted option to develop and commercialize Leap CARLSBAD, Calif. for global rights to INCMGA0012. (NASDAQ:TRVN) and Jiangsu Nhwa Pharmaceutical Co. Alnylam and Dicerna Form RNAi Therapeutics Collaboration on Alpha-1 Antitrypsin Deficiency-Associated Liver Disease and Complete Cross-License Agreement for Primary Hyperoxaluria Programs Alnylam Pharmaceuticals Press Release | Apr 06, 2020 Jan 13, 2020 · MorphoSys and Incyte Sign Global Collaboration and License Agreement for Tafasitamab - MorphoSys and Incyte to co-commercialize tafasitamab in the U. License agreement. Amgen and Serono announced today that they have signed a license and commercialization agreement by which Serono will sell the marketed drug Novantrone® (mitoxantrone for injection concentrate) in the United Mar 31, 2020 · Ultragenyx is a longstanding licensee partner of REGENXBIO. , March 31, 2020 (GLOBE NEWSWIRE) -- REGENXBIO Inc. Valeant will continue to lead development and commercialisation of brodalumab in the US May 05, 2020 · Press Release Genprex Enters Into Exclusive Worldwide Patent and Technology License Agreement for Combination of its TUSC2 Gene Therapy with Immunotherapies Published: May 5, 2020 at 9:17 a. , a veterinary medical device company that develops and manufactures Mitsui Chemicals, Inc. Receive press releases from Prosidyan, Inc. PARIS (FRANCE) AND TARRYTOWN, NY - December 10, 2019 – Sanofi and Regeneron Pharmaceuticals, Inc. for the exclusive worldwide rights to its DermSafe® hand sanitizer made with London, UK; 2nd January 2020 – Imagination Technologies (“Imagination”) announces that it has replaced the multi-year, multi-use license agreement with Apple, first announced on February 6, 2014, with a new multi-year license agreement under which Apple has access to a wider range of Imagination’s intellectual property in exchange for license fees. 01. S. “Microsoft invests $11. and Legend Biotech Ireland Limited (“Legend”), subsidiaries of Genscript Biotech 15 hours ago · This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and Private Securities Litigation Reform Act, as amended, including those relating to the Company’s product development, clinical and regulatory timelines, market Jan 24, 2020 · EAST PALO ALTO, Calif. --(BUSINESS WIRE)--Jan. , Sept. S, or 9 percent of the U. , the Molecularly Imprinted Polymers (MIPs) specialist based in Sharnbrook, United Kingdom, has today announced a collaborative agreement with commercial partners for the co-development and license of a novel MIP-based system with specific applications in the security field. of Chicago in October 2015. (NASDAQ: MEIP) and Kyowa Kirin Co. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that it has entered into a worldwide licensing agreement for a rapid COVID-19, novel coronavirus test developed by the Center of Discovery Ligand disclaims any intent or obligation to update these forward-looking statements beyond the date of this press release, except as required by law. Neither the Company nor Acquiror shall, and neither the Company nor Acquiror shall permit any of its Subsidiaries to, issue or cause the publication of any press release or other public announcement with respect to, or otherwise make any public statement or, except as otherwise specifically provided in this Agreement, any disclosure of nonpublic information to a third party Feb 11, 2020 · Genprex signed an exclusive license agreement with the University of Pittsburgh for a diabetes gene therapy that may have the potential to cure Type 1 and Type 2 diabetes, which together currently affect approximately 30. Patent License Agreement with a Vision to Improved Infertility Treatment Posted May 25th, 2009 for Unisense FertiliTech A/S Unisense FertiliTech A/S receives exclusive license for use of Visible™ Discovery Platform for time-lapse assisted embryo assessment with the EmbryoScope™ Embryo Monitoring System. ) for the development and commercialization of ZILRETTA (triamcinolone acetonide DAZN Agrees to a Technology and Intellectual Property License Agreement with the Kudelski Group. --(BUSINESS WIRE)--Oct. September 5, 2019. 2020. loreal. But in British English, the noun is spelled licence. Apr 21, 2020 · LATEST PRESS RELEASE(S) Mogrify and Sangamo announce collaboration and exclusive license agreement for Mogrify’s iPSC- and ESC-derived regulatory T cells 21st April 2020; Mogrify awarded $1. , Dec. 3 Billion Transaction would result in Zayo becoming a private company World-class network assets well positioned to meet connectivity-driven demand in key North America and Europe markets Global investment firms, EQT and Digital Colony, uniquely positioned to support Zayo in growing its business Zayo Group Holdings Mar 13, 2017 · This press release includes statements that constitute "forward-looking statements," including with respect to whether the global license will permit provide a clear pathway for Mylan to commercialize its trastuzumab product in various markets around the world; any legal uncertainty over the launch of Mylan's trastuzumab; whether the settlement Forward-Looking StatementsThis press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks and May 19, 2020 · Final terms of the license agreement will be based on results of the MTA evaluation and overall diligence. (“OncoMed”), dated April 23, 2019, by and among Mereo and Computershare Inc. 3M and LG-Innotek Complete Patent License Agreement for 3M's Metal Mesh Technology. Nov 27, 2017 · This press release contains forward-looking statements, made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements relating to the potential benefits and results, including financial and operating results, that may be achieved through Biogen’s license agreement with Alkermes WASHINGTON – The United States and Swiss Governments today finalized the terms of the Swiss Humanitarian Trade Arrangement (SHTA), which is now fully operational. , Ltd. At that point, on September 19, Commerce and the Mexican growers could sign a final agreement. (NASDAQ:TRIL) (TSX:TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced that it has entered into a Second Amended and Restated License Agreement (the PRESS RELEASE Kineta Enters Research Collaboration and License Agreement with Pfizer to Develop New Cancer Immunotherapies Kineta Immuno-Oncology to receive $15 million upfront and will be eligible to receive up to $505 million in potential research, development and sales milestone payments MIP Diagnostics Ltd. Under the terms of the agreement, Five Prime will pay Inhibrx a $10 million license fee in return for exclusive, worldwide therapeutic and diagnostic rights to antibodies provided by Inhibrx that bind to GITR, as well as an option to license multi-specific antibodies that bind to GITR and other targets. , a Lubrizol Company, for generic ABRAXANE® Mar 02, 2020 · Press Release: uniQure and Gen-X Enter into Research Collaboration and License Agreement for the Development of Novel Synthetic Promoters March 2, 2020 4:14 pm ET Order Reprints BURLINGTON, Mass. Ltd. Mar 31, 2020 · ROCKVILLE, Md. ROCKVILLE, Md. Seattle Genetics and BeiGene Announce Global License Agreement for Advanced Preclinical Product Candidate. 30, 2019 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a development-stage biopharmaceutical company dedicated to accelerating the advancement of innovative medicines that make a meaningful impact in the lives of patients living with cancer and other serious diseases, today announces an exclusive global license agreement with Jul 22, 2019 · · Over $24M in initial and milestone-based payments. (PRWEB) June 25, 2020 Lumeda Inc. , (NASDAQ: NAOV), a medical device company that produces the UroShield ®, PainShield ® and WoundShield ®, and WoundShield ® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it signed a license agreement with Sanuwave Health, Inc. This press release contains forward-looking statements, including statements related to the anticipated receipt of payments and potential receipt of development and sales milestones, as well as royalties on potential future sales of RT002 under the license with Fosun Pharma; the timing and conduct of regulatory, developmental and commercial NASA Glenn Research Center transfers technology to FLEXcon. Announces License Agreement with Kansas State University Research Foundation for Norovirus and Coronavirus Antiviral Compounds This press release contains forward Zayo Shareholders to Receive $35. 06. The SHTA will further facilitate the flow of humanitarian goods to the Iranian people while safeguarding against the Iranian regime’s diversion of humanitarian trade for malign purposes. ("WiLAN"), a Quarterhill Inc. Please refer to . (NYSE:PFE), today announced that the companies have entered into a worldwide exclusive licensing agreement for AKCEA-ANGPTL3-LRx, an investigational antisense therapy being developed to treat patients with certain cardiovascular and metabolic diseases. 5 Nov 2019 Press Releases. The agreement allows for the production of the HIV medicines tenofovir, emtricitabine, cobicistat, and elvitegravir as well as a combination of these products in a single pill  31 Jan 2014 IBM Press Room - IBM and Twitter announced today that in December Twitter acquired over 900 patents from IBM and that the companies entered into a patent cross-license agreement. , Inc. This transaction provides Nestlé with a strong platform for continued growth in North America with leadership positions in the premium roast and ground and portioned coffee businesses. population. , Jan. , April 01, 2020 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. The companies also have reached a six-year license agreement, effective as of April 1, 2019, including a two-year option to extend, and a multiyear chipset supply agreement. DENVER, Colo. IDEMIA, the global leader in Augmented Identity announces that IDEMIA and IDEX Biometrics ASA, the leading provider of advanced fingerprint identification and authentication solutions have entered a worldwide license agreement for use of IDEX’s biometric enrollment intellectual property. A. Sep 09, 2019 · Under the terms of the agreement, Alexion will acquire an exclusive license for the clinical development and commercialization of AG10 in Japan. 8, 2020-- Xencor, Inc. Patent licensing agreement signifies ZTE's standard setting global leadership in 4G LTE technology. Related XML feeds  ZTE Signs 4G Patent Licensing Agreement with Teltronic. (Nasdaq:RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV Technology Platform, and Ultragenyx Pharmaceutical Inc. Ltd, Japan The companies Purex Co. Read the press release in its entirety here. WOBURN, Mass. ("Skinvisible") (OTCQB:SKVI), is pleased to announce that it has signed a Licensing Agreement with Ovation Science Inc. (virt-x: SEO and NYSE: SRA). Jan 21, 2020 · The new Agreement finalizes the terms of contracts, including the scope of business, the terms of license and defines the specific royalties Yissum would receive in various scenarios (all within Apr 04, 2013 · This section provides and discusses personal release agreements that permit the use of a person’s name and image. Sep 05, 2019 · Sharp has reached a license agreement with Samsung on wireless communication standard essential patent (SEP) license including LTE. , Kenilworth, N. This news release contains forward-looking statements by Ligand that involve risks and uncertainties and reflect Ligand's judgment as of the date of this release. Jan 07, 2020 · The parties also agreed to a mutual release of claims resulting from the License Agreement. Foamix will supply the finished licensed products to Cutia for clinical and commercial use. Before you can install and use a Developer Express Inc product, you must read, understand and accept the terms/conditions of our EULAs. p. PRESS RELEASE . In addition to today's agreement, Ultragenyx has in-licensed NAV Vectors for the development of gene therapies to treat Ornithine Transcarbamylase (OTC) Deficiency, Glycogen Storage Disease Type Ia (GSDIa), CDKL5 Deficiency, Hemophilia A, and Wilson Disease. ET Press Release. Investor: Teri Loxam, 908-740-1986 or 7 Mar 2017 MINNEAPOLIS, March 7, 2017 /PRNewswire/ -- Bio-Techne has entered into an exclusive license agreement with Multiclonal Therapeutics (MCT) to commercialize reagents and media systems in the research reagent field To view the original version on PR Newswire, visit:http://www. Eidos will receive an upfront payment of $25 million and an equity investment of $25 million at a premium to the market price upon deal execution, with the potential for additional Japanese-based ap images : ap images license terms. All statements other than statements of historical fact  9 Oct 2018 Intellectual Ventures founder and CEO Nathan Myhrvold illuminates why people and the planet need every source of reliable, carbon-free energy  2 Jan 2020 Today Imagination posted a short press release as follows: "London, UK; 2nd January 2020 – Imagination Technologies (“Imagination”)  13 Jan 2020 Under the terms of the License Agreement, Oncologie will receive an to future events and anticipated revenues, earnings, cash flows or other  Takeda and TRIANNI Sign Licensing Agreement For Use of TRIANNI Transgenic Mouse Platform. (NASDAQ: REGN) today announced their intent to simplify their antibody collaboration for Kevzara ® (sarilumab) and Praluent ® (alirocumab) by restructuring into a May 28, 2020 · (PRESS RELEASE) PADUA/SHANGHAI – Safilo, a worldwide leader in the design, manufacturing and distribution of eyewear, and Ports (Ports Asia Holding) announce a new ten-year license agreement for the design, manufacture and distribution of Ports branded sunglasses and optical frames. gov KLAMATH, Calif. , FMX103 and FCD105 in the Greater China territory. , Professor of Glyco-Oncology at the university. and L'Oréal announce the signing of a long-term license agreement for the creation, development and distribution of luxury beauty products for the Prada brand. Y. 1 KB Nestlé today announced an agreement granting the company perpetual rights to market Starbucks consumer and foodservice products globally, outside of the company’s coffee shops. PRZOOM - /newswire/ - Cheseaux-sur-Lausanne, Switzerland, 2020/05/26 - The Kudelski Group, the world leader in digital security, today announced a technology and intellectual property license agreement with DAZN, a global leader in digital content distribution - DAZN. Coal-to-Liquids Complex in Mozambique applies Uhde PRENFLO® PDQ process. Finance. (“Lumeda”), a biophotonics systems company formed to advance photodynamic therapy for treating cancer, today announced the company has entered a license agreement with Roswell Park Comprehensive Cancer Center of Buffalo, New York (“Roswell Park”). (Nasdaq:FLXN) today announced that it has entered into an exclusive license agreement with HK Tainuo and Jiangsu Tainuo (a subsidiary of China Shijiazhuang Pharmaceutical Co, Ltd. The Licence shall cover also the  This BRAND LICENSE AGREEMENT (this “Agreement”) is entered into as of events, awards, press releases, quarterly and annual reports, presentations,  The patent is included in Cyxone's license agreement with the Medical University and is entitled “Cyclotides in combination with kappa opioid receptor ligands for  London (July 17, 2019) – Leading brand-licensing agency Global Icons Europe is pleased to announce its worldwide representation agreement with Sparco  12 Dec 2019 The license agreement, having obtained the applicable customary regulatory approvals, will For more information: http://mediaroom. Ennis, the Inspector General for the Social Security Administration, announce the launch of a dedicated online form at https://oig. TRIANNI, Inc. May 12, 2017 · New Balance Announces License Agreement For Sports Monitors With HIGHGEAR® Boston, MA – November 10, 2006 – New Balance Athletic Shoe, Inc. and/or its subsidiaries. - Incyte has exclusive commercialization rights outside of the U. ZUG, Switzerland and CAMBRIDGE, Mass. Jun 04, 2020 · In addition to the $31 million deal announced between the two companies Thursday, they also outlined a separate license agreement in which Medtronic has licensed certain robot-assisted surgical technologies in return for an upfront payment of $10 million. The Federal Trade Commission works to promote competition, and protect and educate consumers. Apr 14, 2020 · SAN DIEGO and TOKYO, April 14, 2020 /PRNewswire/ -- MEI Pharma, Inc. NEW YORK & SOUTH SAN FRANCISCO, Calif--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) and Five Prime Therapeutics, Inc. Weilian Chemical is a subsidiary of Dongying United Petrochemical Co. (NASDAQ:FNJN) a cybersecurity company, announced that on January 23, 2020 its subsidiaries Finjan, Inc. , Finjan Blue and Finjan Mobile (collectively “Finjan”) each entered into a patent license and settlement agreement with BitDefender (“the Agreements”). Press Release License Agreement for Tildrakizumab in Greater China Author: ajay. Press Release. Lund, Sweden – December 23, 2019 – BioInvent International AB (“BioInvent” or the “Company”) Hyatt Hotels Corporation, headquartered in Chicago, is a leading global hospitality company with a portfolio of 20 premier brands. BEVERLY, MA – July 22, 2019 (GLOBE NEWSWIRE) Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to report that the Company has executed a license agreement with Alfasigma S. HORSHAM, PA (December 21, 2017) – Janssen Biotech, Inc. ("Huawei”), one of the world’s largest May 04, 2020 · This press release contains forward-looking statements about the business prospects of BioMarin Pharmaceutical Inc. , June 16, 2020 /PRNewswire Spotify Technology S. PRESS RELEASE December 23, 2019 BioInvent announces selection of second target and extension of the research collaboration and license agreement with Pfizer Inc. 2, 2020 /PRNewswire/ -- Pulmatrix, Inc. I am authorized by my co-authors to enter into these  4 Dec 2019 This section provides and discusses personal release agreements that permit the use of a be used for things like social media and newsletters require releases from their subjects? Woods's licensing people sued and lost. FOR IMMEDIATE RELEASE SPARC and Sun Pharma enter into a worldwide license agreement for SCD-044, a potential treatment for atopic dermatitis, psoriasis and other auto-immune disorders Mumbai, India, May 28, 2020 – Sun Pharma Advanced Research Company Ltd. and NOVATO, Calif. MT. , April 28, 2020 (GLOBE NEWSWIRE) -- InterDigital, Inc. December 2014. November  13 Jan 2020 Sign Global Collaboration and License Agreement for Tafasitamab set forth in this press release contain predictions, estimates and other  24 Jun 2019 The agreement: One state regulatory department reviews common licensing requirements – business plan; direct and indirect owners, including  1 Apr 2019 Intended for international media only/not intended for UK- and Biotechnology and Pierre Fabre Enter into Exclusive License Agreement to Develop and This press release contains forward-looking statements, including  11 Feb 2019 Under the agreement, Moberg Pharma is eligible to receive up to EUR 50 million contingent on Image bank · Press releases Moberg Pharma has entered into a license agreement granting the Consumer Health division of  16 Apr 2019 “This license agreement enables Novasep to secure the right to produce such lentiviral vectors for our customers worldwide. Oct 04, 2017 · RGS Energy Will Host a Conference Call Today at 2:15 p. (Kyowa Kirin, TSE: 4151) today jointly announced that the companies have entered into a global license, development and commercialization agreement to further develop and commercialize MEI's ME-401, an oral, once-daily, investigational drug-candidate, selective for phosphatidylinositol (Philadelphia, December 12, 2016) – The City of Philadelphia today announced a multi-year agreement with Comcast Business for an Institutional Network, commonly called an iNet, and commercial broadband services that will significantly boost the City’s networking speeds and capacity, while reducing costs. Under the agreement, OPPO will make payments to Nokia for a multi-year license period. m. (NASDAQ:AMGN) and Serono S. SAN DIEGO — January 31, 2018 — Qualcomm Incorporated (NASDAQ: QCOM) today announced that it has expanded its global patent cross-license agreement with Samsung covering mobile devices and infrastructure equipment. (NASDAQ:IDCC), a mobile technology research and development company, today announced that, together with its patent holding subsidiaries, it has signed a multi-year, worldwide, non-exclusive, royalty bearing patent license agreement with Huawei Investment & Holding Co. com/news- releases/bio-techne-signs-exclusive-license-agreement-with-multiclonal-  14 Dec 2004 SEOUL, Korea and TOKYO, Japan, December 14, 2004 Samsung Electronics Co . V. , April 2, 2020 /PRNewswire/ -- NanoVibronix, Inc. Mar 21, 2014 · European Commission - Press Release details page - European Commission Press release Brussels, 21 March 2014 The European Commission has adopted new rules for the assessment of technology transfer agreements under EU antitrust rules. Salesone signs an agreement for the licensed Marvel characters and will now be offering body jewelry inspired by them. June 13, 2019. (Shenzhen Stock Exchange:002262) announced today that they have entered an exclusive license agreement for the development and commercialization of Trevena’s investigational product oliceridine. It also allows Nestlé to Jul 10, 2019 · Home Investors News releases News release details MacroGenics and I-Mab Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Enoblituzumab in Greater China << Back Jul 10, 2019 Jan 02, 2020 · LEXINGTON, Mass. About Incyte Incyte Corporation is a Wilmington, Delaware -based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. to Develop and Commercialize Ivermectin Lotion, 0. to develop a novel HSV-2 vaccine using Genocea&CloseCurlyQuote;s proprietary HSV-2 antigens May 05, 2020 · Statements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. 29, 2020, 08:30 AM Jun 04, 2020 · Press Release Titan Medical Announces Development and License Agreements With Medtronic and Senior Secured Loan Published: June 4, 2020 at 8:30 a. LEXINGTON, Mass. The agreement, which is set to cover the Mainland China This license agreement opens several development opportunities for us to expand the broad utility of our platform to address significant viruses for which there are unmet medical needs, particularly the COVID-19 coronavirus and norovirus,” commented Dr. uniQure N. License as a Noun: Spelling and Examples. March 31, 2014 /. AVEO and EUSA Pharma Announce Exclusive Licensing Agreement for Tivozanib in Europe Under the terms of the agreement, EUSA Pharma will pay AVEO an upfront research and development funding  Press Release: New license agreement brings hope to HIV positive children. , resolving the global patent infringement litigation brought by Immersion against Samsung. This press release contains express and implied forward-looking statements, including, but not limited to, statements regarding Nutanix’s and HPE’s business plans and objectives, the benefits and capabilities of Nutanix’s Enterprise Cloud OS software on the HPE GreenLake as a Service solution, the benefits and capabilities of an Scientists will have new view into natural cell activity, accelerating drug development (December 19, 2019) Promega Corporation today announced it has signed a license agreement with MilliporeSigma, a leader in genome editing, to access MilliporeSigma’s foundational CRISPR genome-editing technology. (NYSE:JW-A) (NYSE:JW-B), today announced a new license agreement with the country of Brazil that provides unlimited access to the Cochrane Library . --(BUSINESS WIRE)--Apr. (NASDAQ: IONS) and Pfizer Inc. (NASDAQ:IDCC), a mobile and video technology research and development company, today announced that, together with its patent holding subsidiaries, it has signed a multi-year, worldwide, non-exclusive, royalty bearing patent license agreement with Huawei Investment & Holding Co. (NASDAQ: IONS) announced today that its license agreement with Roche to develop and commercialize IONIS-HTT Rx for the treatment of people with Huntington's disease (HD) has received clearance under the Hart-Scott-Rodino Antitrust Improvements Act. (“Gimlet”), the renowned independent producer of podcast content, and Anchor (“Anchor”), the company leading the market for podcast creation, publishing, and monetization services. 30 AM CET - Prada S. (NYSE:SPOT) (the “company”), the world’s most popular music streaming service, today announced that it has entered into definitive agreements to acquire Gimlet Media Inc. Press Release 09 June 2020 Siemens and Exyte join forces to deliver integrated solutions for fast-track construction of smart biotech facilities Covid-19 poses major challenges for developing and mass-producing vaccines and medicines in existing production facilities You may terminate this License Agreement at any time by destroying the Faulkner Press Software and all copies thereof. (NASDAQ: AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc. Within the first 60 days of the Agreement Effective Date, the Trust agrees to review in good faith a press release (in any format or medium) announcing the Agreement with Distributor; provided that Distributor must obtain the Trust’s prior written consent prior to publication of such release, which consent may only be reasonably denied by the Trust. WILMINGTON, Del. , March 24, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. Akcea Therapeutics, Inc. 08. 02, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. The agreement provides Lenovo with a license to use SIE’s patented PlayStation®VR (PS VR) industrial design for the Lenovo Mirage Solo virtual reality headset. “This news release does not constitute an offer to sell, or a solicitation of an  31 Mar 2020 This press release includes "forward-looking statements," within the meaning of Section 27A of the Securities Act of 1933, as amended, and  23 Mar 2020 Codexis Signs Strategic Collaboration and License Agreement with Takeda to Advance Novel Gene Therapies for To the extent that statements contained in this press release are not descriptions of historical facts regarding  Press release: Oxurion and Inceptua Group enter global license agreement for the commercialization of JETREA® Oxurion announces the signing of a JETREA ® global license agreement with Inceptua Group. (“Janssen”), one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that it has executed a global license and development agreement with the Danish company Genmab A/S for the anti-cancer compound, daratumumab. Optodot and LG Chem Sign Patent License Agreement . J. 21 hours ago Press release Oncology Venture signs agreement to out-license two pipeline assets as part of prioritized portfolio strategy  Systasy Bioscience GmbH and Boehringer Ingelheim International GmbH(BI) entered a non-exclusive license agreement for cell-based splitSENSOR assays  InterDigital Signs License Agreement With Huawei. It is the largest civil penalty the agency has proposed against a UAS operator. Ltd, leader in the Japanese laundry machinery market, and Jensen Denmark A/S, a subsidiary of the Jensen-Group, are pleased to announce that they have signed agreements covering technical collaboration in the fields of finishing Wi-LAN Inc. Press Release JENSEN Denmark AS signs license agreement with Purex Co. 03, 2020 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. — The U. and BERLIN, Germany, J an. Mar 23, 2020 · REDWOOD CITY, Calif. 6 billion in milestone payments for the HBV license agreement, including a $50 million milestone payment linked to a Phase 2 study. the following terms and conditions ("license terms") govern your right to use any photographic images, graphic images, text, captions or audio-visual files (collectively, "content") that you access (whether by download, separate electronic or wireless delivery, or delivery by physical media, collectively "access") via this ap images website (the "site"). PRESS RELEASE April 16, 2019  Back to press releases. As used below and throughout this press release, the words “we”, “us” and “our” may refer to Fortress individually or together with one or Jun 29, 2020 · june 29 (reuters) - oncology venture a/s: * reg-press release oncology venture signs agreement to out-license two pipeline assets as part of prioritized portfolio strategy This press release may contain a number of “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including statements regarding CRISPR Therapeutics’ expectations about any or all of the following: (i) the intellectual property coverage and positions of CRISPR Therapeutics, its “PSCA is an attractive target for our CAR-T cell technology and the license agreement allows Bellicum to advance BPX-601 into a number of cancers where there is a significant unmet medical need,” commented Bellicum’s President and CEO Thomas J. Patent license permits LG Chem to utilize boehmiteseparators for lithium -ion batteries . ZURICH & CAMBRIDGE, Mass. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such MONROVIA, Calif. The agreement settles enforcement cases involving a $1. This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including, without limitation, statements regarding Ipsen’s plan to develop and commercialize BLU-782 or any other licensed products under the license agreement; potential payments under the license May 11, 2020 · AUSTIN, Texas, May 11, 2020 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. Dec 21, 2015 · The agreement includes a cross license that covers patents relating to both companies' standard-essential patents (including the GSM, UMTS and LTE cellular standards), and grants certain other patent rights. Andrew Saul, Commissioner of Social Security, and Gail S. Department of the Interior, U. (Nasdaq:RARE), a biopharmaceutical company focused on the development and commercialization SAN MATEO, Calif. , USA (the “company”) includes “forward-looking statements” within the meaning of the Media: Pam Eisele, 267-305-3558 or. (Nasdaq: RMNI), a global provider of enterprise software products and services, the leading third-party support provider for Oracle and SAP software products and a Salesforce partner, today announced that Airservices Australia, Australia's air navigation service provider, has further extended the Jun 25, 2020 · ROCKY HILL, Conn. Apr 23, 2020 · Under the terms of the agreement, Cutia will have an exclusive license to obtain regulatory approval of and commercialize AMZEEQ™ and, if approved in the U. - MorphoSys and Incyte to host joint conference call on January 13, 2020 at 7:00am PST / 4:00pm CET Gilead Terminates License Agreement for Long-Acting Injectable HIV Investigational Product The statements in this press release regarding clinical development plans for DUR-928, including the 21 hours ago · Press release Oncology Venture signs agreement to out-license two pipeline assets as part of prioritized portfolio strategy Article Comments (0) FREE Breaking News Alerts from StreetInsider. ThyssenKrupp Uhde and SGC Energia (SGCE) have entered into a Master License and Supply Agreement for the application of ThyssenKrupp Uhde’s proprietary PRENFLO® PDQ coal gasification technology. MPV acquired the iconic Kodak digital imaging portfolio of nearly 4,000 … DALLAS, February 2, 2015 – Flowserve Corporation (NYSE: FLS), a leading provider of flow control products and services for the global infrastructure markets, today announced it has signed a license agreement with New Way Air Bearings to develop externally pressurized solutions for its seal and pump operations. doi. ET Nestlé today announced an agreement granting the company perpetual rights to market Starbucks consumer and foodservice products globally, outside of the company’s coffee shops. Jun 29, 2020 · Press release Oncology Venture signs agreement to out-license two pipeline assets as part of prioritized portfolio strategy Stockholm Stock Exchange:OV Hørsholm, Denmark (29 June 2020) – Oncology 20 hours ago · Press release Oncology Venture signs agreement to out-license two pipeline assets as part of prioritized portfolio strategy PRESS RELEASE GlobeNewswire Jun. (Nasdaq: PSTV) (the “Company”, “Plus”), today announced the closing of its previously announced definitive agreement to license multiple rare cancer product candidates from private Texas-based radiotherapeutic company NanoTx Therapeutics, Inc. In American English, the noun is spelled the same as the verb—license. 3 million people in the U. (“FlowPlay”), a developer and publisher of community-based online social games. : RSS Feeds: Prosidyan Announces an Exclusive Joint Collaboration and License Agreement with MO-SCI Corporation for an Mar 13, 2020 · Press release: Oxurion and Inceptua Group enter global license agreement for the commercialization of JETREA® Oxurion announces the signing of a JETREA® global license agreement with Inceptua Group. (Reuters: SPRC. 4, 2017-- Gilead Sciences, Inc. HORSHAM, PA (August 30, 2012) – Janssen Biotech, Inc. prnewswire. You can learn more about consumer topics and file a consumer complaint online or by calling 1-877-FTC-HELP (382-4357). March 31, 2020 at 2:00 AM EDT This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including our expectations regarding the timing for achievement of certain research and clinical development milestones related to the licensing agreement with Merck as well as royalties on any product sales. Back to press releases. In submitting an article to any of the journals published by BMC I certify that;. Under the Termination and Release Agreement, Bhang will receive royalty payments, input materials, manufacturing equipment, Bhang-branded finished goods, and Origin House shares, collectively valued at approximately US$1. Today’s agreement builds on Toyota and Microsoft’s strong partnership, which includes their collaboration on the Azure-based Toyota Big Data Center. But license can also be used as a noun, which is where the different spellings come into play. (“Genprex” or the “Company”) (Nasdaq: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced that it has entered into a Patent and Technology License Agreement (“License Agreement”) with The University of Texas MD Anderson Cancer Center Axovant Announces Global Licensing Agreement for AXO-AAV-OPMD Program for Treatment of Oculopharyngeal Muscular Dystrophy and Broader Platform Collaboration with Benitec Biopharma 07. C. Press Release WALTHAM, Mass. As of December 31, 2019, the Company's portfolio included more than 900 hotel, all-inclusive, and wellness resort properties in 65 countries across six continents. (hereafter Samsung) and Sony Corporation (hereafter Sony) have signed a Cross-License Agreement on December 14, detailing mutual  15 Oct 2018 Sarepta and Lysogene Announce Exclusive License Agreement for LYS-SAF302 , a Late-stage Gene Therapy for Any statements contained in this press release that are not statements of historical fact may be deemed to be  21 Dec 2017 Under terms of the agreement, Legend will grant Janssen a worldwide license to jointly develop and This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995  12 Jun 2011 This press release is also available as a PDF here. Mogrify and Sangamo Announce Collaboration and Exclusive License Agreement for Mogrify’s iPSC- and ESC-Derived Regulatory T Cells CAR-T BCMA in Development for Patients with Multiple Myeloma . (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer, autoimmune disease, asthma and allergic diseases, today announced it has entered into a technology license agreement in which Gilead Sciences, Inc. ). May 19, 2020 · Genocea Announces Material Transfer and License Option Agreement with Shionogi for Proprietary GEN-003 HSV-2 Antigens PRESS RELEASE GlobeNewswire May. ” He added: “It is an  The companies have reached a global patent license agreement and a chipset supply agreement. (NASDAQ:GILD) announced today a new licensing agreement with the Medicines Patent Pool (MPP), a United Nations-backed public health organization, to expand access to bictegravir (BIC) upon regulatory approval in the United States. SUPERINTENDENT OF FINANCIAL SERVICES LINDA A. Words such as "may," "will," "expect," "plan," "anticipate," "estimate," "intend" and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are intended Oct 30, 2018 · KemPharm’s product pipeline is focused on the high need areas of ADHD, pain and other central nervous system disorders, and its co-lead clinical development candidates, KP415 and KP484, are both based on a prodrug of d-methylphenidate, but with differing extended-release/effect profiles, and are intended for the treatment of ADHD. that includes broad coverage for connected car technologies. Trianni /. 2018 PDF Version New COVID-19 assay will be adapted to run on T2 Biosystems’ FDA-cleared T2Dx® Instrument. The agreement resolves the Department’s lawsuit alleging that the county discriminated against an applicant on the basis of his disability, dwarfism, when he sought to apply for a Purchasing Manager position. (TRA) for new end uses of Ultra-Fresh antimicrobials to be used in Soft-Tex’s new collection of BioPEDIC® Fresh & Clean bedding products. Under this Agreement the Licensor hereby provides the Licensee with a licence to use the Software (hereinafter: 'Licence'). (“Janssen”), a Janssen Pharmaceutical Company of Johnson & Johnson, announced today that it has entered into a worldwide collaboration and license agreement with Legend Biotech USA Inc. This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks, uncertainties and other factors, including the risk that the parties may not realize the potential benefits of this collaboration program and Gilead may fail to develop and/or commercialize May 28, 2020 · BP has entered into an agreement to license its latest generation technology for the production of purified terephthalic acid (PTA) to China’s Dongying Weilian Chemical Co. Download PDF Format 3M Media Contact: Donna Fleming Runyon, (651) 736-7646. Arrowhead is also eligible to receive approximately $1. Aug 20, 2019 · Qualcomm products mentioned within this press release are offered by Qualcomm Technologies, Inc. for the MPV Kodak digital imaging portfolio. Under the terms of the agreement, IDEX has granted IDEMIA a license to use some IDEX patents in order to New National License Agreement Provides Brazil with Unlimited Access to the Cochrane Library Login HOBOKEN, N. The announcement puts an end to several years of speculation as to the relationship between Imagination  21 Dec 2019 Press Release. Sunshine Health Supports Community during the COVID-19 Pandemic. Press Release Amunix Pharmaceuticals Announces Technology Licensing Agreement with Roche to Advance Novel Therapeutics Outside Oncology Amunix to receive $40 million in upfront payment and may receive up to $1. Release Date:2016-03 -01 Author:ZTE Click:511. Apr 21, 2020 · This press release features multimedia. pdf 78. for the manufacture and delivery of its WoundShield Recommend Bachem and Jitsubo enter into exclusive Licensing Agreement press release Download and print your digital press kit now Please send the following information to my e-mail address: Press Releases The Office of the Spokesperson releases statements, media notes, notices to the press and fact sheets on a daily basis. com! WATERTOWN, Mass. 4. This agreement will allow the two companies to combine their expertise in each of their own sectors. Publication Agreement This is a publication agreement1 (“this agreement”) regarding a written manuscriptcurrentlyentitled (“thearticle”)tobepublishedinPMLR(“theproceedings”). The parties shall consult with each other in preparing any press release, public announcement, news media response or other form of release of information concerning this Agreement or the transactions contemplated hereby that is intended to provide such information to the news media or the public (a “Press Release”). Notwithstanding the foregoing, IDCC and Licensee shall each have the right to publish and distribute a press release announcing the execution of this License Agreement. (“NuWave”) to evaluate the potential commercial use of the Company’s Radiant Energy Vacuum (“REV™”) dehydration technology. Jul 01, 2016 · In September 2015, AstraZeneca and Valeant entered an agreement granting Valeant an exclusive licence to develop and commercialise brodalumab globally, outside Japan and certain other Asian countries where the rights are held by Kyowa Hakko Kirin Co. Department of Commerce, PacificCorp, and the states of Oregon and California today signed an agreement that, following a process administered by the Federal Energy Regulatory Commission (FERC), is expected to remove four dams on the Klamath River by 2020 Apr 21, 2020 · Press release content from Business Wire. 22, 2019 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, and ProBioGen, a premier German service and technology provider, today announced a multi-year research collaboration focused on the development of novel in vivo May 14, 2020 · EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”), announced today that it has signed a Technology Evaluation and License Option Agreement (the “Agreement”) with a Canadian food company NuWave Foods Inc. Partnerships and programs address social determinants of health needs throughout Florida SUNRISE, Fla. The AP news staff was not involved in its creation. , October 30, 2018 - Sony Interactive Entertainment (SIE) and Lenovo announced today they have signed a two-year patent license agreement. , as rights agent, (the “Mereo CVR Agreement”), holders of Kineta Enters Research Collaboration and License Agreement with Pfizer to Develop New Cancer Immunotherapies Kineta Immuno-Oncology to receive $15 million upfront and will be eligible to receive Hørsholm, Denmark (29 June 2020) – Oncology Venture A/S (“OV” or the “Company”) today announced that it has signed a definitive agreement out-licensing two clinical pipeline assets, LiPlaCis® and 2X-111, to Smerud Medical Research International for further clinical and commercial development. ("Huawei”), one of the world’s LONDON, June 13, 2018 /PRNewswire/ — International Game Technology PLC (“IGT”) (NYSE: IGT), holder of the largest slot game feature patent portfolio in North America, announced that it has signed a patent cross-license agreement with FlowPlay, Inc. Inks License Agreement with MARVEL. khodke Created Date: 6/27/2019 2:04:55 PM Jan 06, 2020 · GlycoMimetics and Apollomics Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Uproleselan and GMI-1687 in Greater China January 6, 2020 at 9:00 AM EST PDF Version May 08, 2020 · This press release may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. Personal releases are often referred to as “model releases,” although the term “model” can be used for anyone, not just professional models. , April 18, 2016 — Optodot Corporation recently granted a license to LG Chem Ltd. 04, 2017 (GLOBE NEWSWIRE) -- RGS Energy (NASDAQ:RGSE) has entered into an exclusive domestic and international license agreement with The Dow Chemical Company for the POWERHOUSE™ solar shingles system, an innovative and aesthetically pleasing solar shingle system developed by Dow that has been deployed on more Apr 06, 2016 · Date: April 6, 2016 Contact: Jessica Kershaw, interior_press@ios. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that it has entered into a worldwide licensing agreement for a rapid COVID-19, novel coronavirus test developed by the Center of Discovery LAS VEGAS, June 29, 2020 - Rimini Street, Inc. , April 28, 2020 (GLOBE NEWSWIRE)  5 Sep 2019 Sharp has reached a license agreement with Samsung on Press Releases · Back To Index · Press Release Search. 22 Tillotts Pharma AG signs license agreement on antibody technology with Inven2 Apr 02, 2020 · ELMSFORD, N. SkyPan Press Release ### Press Release Jun 24, 2020 12:00 UTC Alteogen Enters into a Global License Agreement with a Top Ten Pharmaceutical Company for Use of Its Hybrozyme™ Technology to Enable Subcutaneous Administration of Biologic Products May 19, 2020 · CAMBRIDGE, Mass. ) Export Law Assurances. , Oct. Agreement will end on October 31, 2020. , March 23, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. under a patent portfolio controlled by Optodot covering batteries, cells, separators and The information in this press release contains forward-looking statements and information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the “safe harbor” created by those sections. Select a topic or year. “We look forward to the expected advancement of BPX-601 into clinical development in WILMINGTON, Del. L’Oréal Signs Agreement to Acquire Thayers Natural Remedies, a US-based Natural Skincare Brand L’Oréal Signs Agreement May 13, 2019 · SAN JOSE, Calif. D. Jun 10, 2019 · The Department of Justice today announced that it reached a settlement agreement with York County, South Carolina, under the Americans with Disabilities Act (ADA). THOUSAND OAKS, California, USA and GENEVA, SWITZERLAND - November 13, 2002 - Amgen Inc. The service is accompanied by biographies of the board of management, speeches, image galleries with free-to-use photographs, a tv-service, audio and video podcasts, an Apr 09, 2019 · Expanded license creates opportunity for vadadustat to be provided to up to 60% of U. Both potential programs will focus on targets in which healthy tissue expression does not permit development of ADCs incorporating traditional antibodies. Jul 25, 2019 · The forward-looking statements contained in this press release reflect Verastem Oncology’s views as of the date hereof, and the Company does not assume and specifically disclaims any obligation to update any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. (Nasdaq:FPRX) today announced that they have entered into an exclusive worldwide license and collaboration agreement for the development and commercialization of Five Prime’s colony stimulating factor 1 receptor (CSF1R) antibody program, including FPA008 which is Mar 31, 2020 · REGENXBIO and Ultragenyx Announce New License Agreement for Use of NAV® Technology Platform for the Treatment of Rare Metabolic Disorder March 31, 2020 at 4:05 PM EDT - REGENXBIO grants Ultragenyx exclusive, worldwide rights to NAV AAV8 and AAV9 Vectors for the development and commercialization of gene therapy treatments for a rare metabolic Jan 08, 2020 · Updated Press Release: Targovax and IOVaxis Therapeutics Enters Option Agreement for TG Mutant RAS Vaccine License and Clinical Development in China PR Newswire OSLO, Norway, Jan. Jan 31, 2018 · Qualcomm products mentioned within this press release are offered by Qualcomm Technologies, Inc. 8, 2020 (Updated ADC Therapeutics has entered into the agreement with Adagene for one exclusive target, with the option to leverage SAFEbody technology for one additional exclusive target. on Wednesday announced a new patent licensing agreement with Toyota Corp. These forward-looking statements speak only as of the date of this press release and Dec 10, 2019 · Sanofi and Regeneron announce intent to restructure Antibody collaboration for Kevzara ® (sarilumab) and Praluent ® (alirocumab). Publicity. Salesone Int. Sharp has now licensed LTE SEPs to many leading vendors and now includes Samsung. 9 million civil penalty that the FAA proposed against SkyPan International, Inc. BO, Press Release: Share Blog. articles are published. ("Quarterhill") company (TSX: QTRH) (OTCQX: QTRHF), announced today that Polaris Innovations Limited ("Polaris"), a wholly owned subsidiary of WiLAN, has entered into a license agreement with United Microelectronics Corporation ("UMC") regarding certain Polaris patents relating to semiconductor manufacturing process technologies. This caution is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. , will access Xencor’s Xtend™ extended half-life May 01, 2018 · CHESTERBROOK, Pa. The statute requires a 30-day notice period after today’s initialing of the draft agreement. JETREA® is… 2 Jan 2020 The very brief and succinct press release details that the new agreement replaces the initial agreement signed in 2014. Sep 12, 2018 · This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Press Release: Share Blog. Ian McConnell, 908-740-1921 or. Datable expects gross margin to be about 55% in 2020 compared to 68% in 2019 due to a change in the product mix. Farrell. (NASDAQ: EYPT), a biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today announced that it has signed an exclusive license agreement with Equinox Science, LLC, to develop vorolanib, a tyrosine kinase inhibitor Dec 19, 2019 · The collaboration agreement grants Takeda an exclusive worldwide license to co-develop and co-commercialize RIVAL-01 with Turnstone, with global costs and profits shared 50:50. Arrowhead is eligible to receive up to approximately $1. (Nasdaq: AKBA) today announced that the companies have amended the terms of their license agreement to sell vadadustat to Fresenius Medical Press Release License Agreement for Tildrakizumab in Greater China Author: ajay. 18, 2017 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. dialysis patients, subject to FDA approval. LACEWELL ANNOUNCES APPROVAL OF FIRST GOLD-BACKED VIRTUAL CURRENCY IN NEW YORK STATE Paxos Trust Company LLC, an Existing DFS Licensee, is Now Authorized to Offer “PAX Gold” DFS Also Authorizes Paxos to Offer “BUSD” Stablecoin Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Instituto Butantan, Sao Paulo, Brazil, a non-profit producer of immunobiologic products for Brazil today announced a collaboration agreement to develop vaccines to protect against dengue virus disease, the mosquito-borne infection. 1M additional funding from SBRI Healthcare 28th January 2020 Aug 21, 2019 · In addition, the draft agreement allows the Department to audit up to 80 Mexican tomato producers per quarter, or more with good cause. Press Releases. Jan 09, 2019 · January 09, 2019 04:12 AM Eastern Standard Time DALLAS–(BUSINESS WIRE)–Dominion Harbor Enterprises, a patent transaction and advisory company, announced today that its subsidiary, Monument Peak Ventures (MPV), has entered into a patent license agreement with Garmin® Ltd. The statements in this release and oral statements made by representatives of Emisphere relating to matters that are not historical facts (including without limitation those regarding the timing or potential outcomes of research collaborations or clinical trials, any market that might develop for any of Emisphere's product candidates and the Oct 30, 2007 · Lilly and Glenmark Pharmaceuticals Announce License Agreement Lilly to Acquire Next Generation Molecule GRC 6211 for the Potential Treatment of Pain, Including Osteoarthritic Pain INDIANAPOLIS, IN The Bayer media server provides press releases from the Bayer Holding, the Subgroups and Service Companies for journalists, bloggers, shareholders and other interested parties. Such press release shall contain the names of the parties, the scope and fields of the license, the license duration, and any other information necessary to satisfy SEC, NASDAQ Jun 19, 2019 · Scope of the collaboration expands to include up to 12 rare disease targets and includes Arcturus nucleic acid technologies to enable mRNA, DNA, and siRNA therapeutics; $30 million of upfront payments to Arcturus, including $6 million cash for collaboration agreement amendment and a $24 million equity investment at $10 per share Sep 30, 2019 · DURHAM, N. —Feb. and XUZHOU, China, May 01, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. , Feb. BIC is a novel investigational integrase Apr 16, 2019 · The settlement includes a payment from Apple to Qualcomm. Nov 14, 2019 · Exicure and Allergan Enter Into Collaboration, Option and License Agreement to Discover and Develop SNA-based Treatments for Hair Loss Disorders - Exicure to Receive $25 Million Upfront Payment Dec 22, 2014 · Home Investors News releases News release details MacroGenics Enters Collaboration and License Agreement with Janssen to Develop MGD011 for Multiple B-Cell Malignancies << Back Dec 22, 2014 Nov 27, 2017 · This press release contains forward-looking statements, made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements relating to the potential benefits and results, including financial and operating results, that may be achieved through Biogen’s license agreement with Alkermes Download this Press Release PDF Format (opens in new window) New agreement gives SouthRock, a leading multi-brand restaurant operator, the rights to develop and operate Starbucks® stores in Brazil – building on more than a decade of business growth, brand loyalty and trust in the market Myovant Sciences and Gedeon Richter Enter into Exclusive License Agreement to Commercialize Relugolix Combination Tablet for Uterine Fibroids and Endometriosis in Certain Territories Outside the U. ssa. , a leading protein engineering company and developer of novel biotherapeutics, announces the signing of a strategic collaboration and license agreement with Takeda Pharmaceutical Company Limited (Takeda) for the research and development of novel gene therapies for certain Press Release / Feb 28, 2019 Licensing Agreement with Arbor Pharmaceuticals, LLC. May 19, 2020 · This press release includes forward-looking statements, including statements relating to GEN-009 and GEN-011, within the meaning of the Private Securities Litigation Reform Act. , December 12, 2017 — Palleon Pharmaceuticals, a company focused on developing Glycoimmune Checkpoint Inhibitors to treat cancer, today announced an agreement with King’s College London to license intellectual property developed in the laboratory of Joy Burchell, Ph. , March 31, 2020 /PRNewswire/ -- REGENXBIO Inc. Milan and Clichy, 12 December 2019, 08. A (“Alfasigma”) to develop and commercialize locally-administered Brilacidin (e. 3. May 23, 2017 · press release may 23, 2017 Nokia and Apple sign patent license and business cooperation agreement, settle all litigation Cupertino, California and Espoo, Finland — Nokia and Apple announced today that they have settled all litigation related to their intellectual property dispute and agreed a multi-year patent license. (Nasdaq:RARE), a biopharmaceutical company focused on the development and commercialization of This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws, including statements regarding future development and potential commercialization activities of the specified product candidate under the agreement with Seattle Genetics, potential FOR IMMEDIATE RELEASE. 24, 2020 (GLOBE NEWSWIRE) -- Finjan Holdings, Inc. Espoo, Finland - Nokia announced that it has signed a patent license agreement with OPPO. g. FOSTER CITY, Calif. JETREA® is a first-in-class pharmacological vitreolysis therapy approved for treatment of symptomatic vitreomacular adhesion or vitreomacular Skinvisible Announces License Agreement Thursday, February 13, 2020 6:00 PM LAS VEGAS, NV / ACCESSWIRE / February 13, 2020 / Skinvisible, Inc. Japan) for SI-6603 Ferring disclosed the press release regarding this agreement on August 29, 2016 (local time). The Ecumenical Advocacy Alliance (EAA) applauds the licensing agreement announced on 1 December by the Medicines Patent Pool ( MPP)  Whatever type of business you have, you'll need to use various media licensing agreements to protect your intellectual property You'll need to use a Video Clearance or Release form to obtain permission to use clips from any video or audio  28 Nov 2019 Couperin, the French academic consortium for higher education and research and Elsevier, a global information analytics business specializing in science and health, has signed a new national license agreement. 06, 2016 (GLOBE NEWSWIRE) -- InterDigital, Inc. 5% in Japan for Head Lice Feb 28, 2019 WALTHAM, Mass. --(BUSINESS WIRE)--May 13, 2019-- Immersion Corporation (NASDAQ:IMMR), the leading developer and licensor of touch feedback technology, today announced that it agreed to enter into a settlement and license agreement with Samsung Electronics Co. com. Print Version. This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws, including statements regarding future development and potential commercialization activities of the specified product candidate under the agreement with Seattle Genetics, potential BALLERUP, Denmark, April 15, 2020 – LEO Pharma A/S, a global leader in medical dermatology, today announced that is has signed a worldwide exclusive licensing agreement with Oneness Biotech (Taiwan, TPEx: 4743) and Microbio Shanghai (China) covering the development and commercialization of the novel Atopic Dermatitis (AD) and Allergic Asthma REGENXBIO Announces Exclusive Worldwide Option and License Agreement with Clearside Biomedical for Evaluation of In-Office Delivery Platform for RGX-314 September 4, 2019 at 7:00 AM EDT - REGENXBIO expands RGX-314 gene therapy program to evaluate Clearside's proprietary, in-office SCS Microinjector™ platform targeting suprachoroidal space Press Release. Sam Lee, President of Cocrystal. com/en/. Qualcomm Incorporated (NASDAQ: QCOM) today announced that LGE has entered into a new direct worldwide patent license agreement with Qualcomm. AddThis Sharing  20 Aug 2019 Qualcomm products mentioned within this press release are offered by agreement, Qualcomm has granted LGE a patent license to develop,  17 Dec 2019 Certain statements contained in this press release constitute "forward-looking statements". The following is an excerpt from a press release from uniQure. PRESS RELEASE: Vexti Signs License Agreement "This cutting-edge technology will have a significant impact in many consumer, medical, and industrial services and products," said Terry McGarty Jun 25, 2020 · WATERFORD, N. — March 22, 2017 — Microsoft Corp. 1 March 2016, Shenzhen, China   29 Aug 2016 the companies have entered into an exclusive worldwide license agreement ( excluding. Forward-looking statements in this press release should be evaluated together with the many uncertainties that affect Bristol-Myers Squibb's business, particularly those identified in the cautionary factors discussion in Bristol-Myers Squibb's Annual Report on Form 10-K for the year ended December 31, 2014 in our Quarterly Reports on Form 10-Q Feb 24, 2020 · Cocrystal Pharma, Inc. 9, 2019-- The Vifor Pharma Group (SIX: VIFN) and Akebia Therapeutics, Inc. Cheseaux-sur-Lausanne, Switzerland, and Phoenix (AZ), USA, May 26th, 2020 – The Kudelski Group (SIX: KUD. Hookipa and Gilead Enter into a Collaboration and License Agreement to Develop Immunotherapies Against HIV and Hepatitis B June 5, 2018 at 2:07 PM EDT Releasec191802a-7617-44d1-8107-3c51a633d017_2353339. Financial terms were not disclosed. 4 billion annually in The information on its website does not, however, form a part of this press release. 3 Dec 2019 By signing an agreement with Avanci, Volvo Cars receives licenses to the 2G, 3G , and 4G essential patents of the 36 patent owners that  19 Feb 2019 Global cross license covering 2G, 3G and 4G patent portfolios On-going royalty payment from Subscribe to Ericsson press releases here. 18. 19, 2020, 01:30 PM Press Release For Immediate Release Glenmark announces Strategic Development and Global Licensing Agreement with Particle Sciences, Inc. announces today that a licensing agreement has been signed with Highgear USA for the New Balance Sports Monitors category. Like the FTC on Facebook, follow us on Twitter, read our blogs and subscribe to press releases for the latest FTC news and resources. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today announced it has entered into a material transfer agreement (MTA) and exclusive license option with Shionogi & Co. 1M. 9 billion in option and milestone payments for the collaboration agreement related to up to three New COVID-19 assay will be adapted to run on T2 Biosystems’ FDA-cleared T2Dx® Instrument. Company Release - 4/28/ 2020 8:00 AM ET. The complaint alleges Jun 15, 2018 · Trillium to issue C$3 million of common shares to retire sublicense revenue sharing provision TORONTO, June 15, 2018 (GLOBE NEWSWIRE) - Trillium Therapeutics Inc. khodke Created Date: 6/27/2019 2:04:55 PM Jul 02, 2019 · In 2017, Incyte entered into an exclusive global collaboration and license agreement with MacroGenics, Inc. gov to receive reports from the public of Social Security-related scams. Mar 24, 2019 · Dallas, TX (March 19, 2019) - Increment Power LLC has entered into an exclusive license agreement with PowerPHASE LLC covering deployment of performance-enhancing PowerPHASE technologies The terms of our license are fully outlined/described in the Developer Express Inc End User License Agreement (EULA) included with our product installations. , Ltd, one of the leading manufacturers and distributors of petroleum and petrochemical products Jan 22, 2018 · News & Events » Press Release » Tillotts Pharma AG signs license agreement on antibody technology with Inven2 2018. These are posted to our website as they are released throughout the day. 5 billion in development and sales milestones May 05, 2020 · AUSTIN, Texas — (May 5, 2020) — Genprex, Inc. (2019/ASML and Mitsui Chemicals Sign License Agreement for EUV pellicle business)Mitsui Chemicals is a Japanese chemical company which develops business globally. This License Agreement will also terminate automatically without notice from Faulkner Press after the academic term in which the Faulkner Press Software is assigned to you as a student in a class. com / NAGRA. These include statements regarding the potential for venBio’s portfolio companies entering into the platform license agreement under which Ligand may receive annual platform access Social Security Administration and its Inspector General Announce New Online Reporting Form for Imposter Scam Calls. As a consequence of the License Agreement with Oncologie, and in accordance with the terms and conditions of the Contingent Value Rights Agreement for former stockholders of OncoMed Pharmaceuticals, Inc. 25 May 2017 Merck Enters Exclusive Worldwide License Agreement with Teijin Pharma for Investigational Antibody Candidate Targeting Tau This news release of Merck & Co. News release. (NASDAQ: EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for treating diseases and disorders of the eye, announced today the execution of a license agreement with SentrX™ Animal Care, Inc. 6, 2018— John Wiley and Sons Inc. 00 per share in Cash Transaction Valued at $14. , May 19, 2020 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. This license agreement opens several development opportunities for us to expand the broad utility of our platform to address significant viruses for which there are unmet medical needs, particularly the COVID-19 coronavirus and norovirus,” commented Dr. In addition, the agreement includes releases that resolve all pending patent-infringement litigation between the companies. (PRWEB) June 25, 2020 Soft-Tex International is pleased to announce it has entered into an expanded trademark license agreement with Thomson Research Associates, Inc. View the full release here: https: "This license agreement provides Sangamo with access to Mogrify's cell conversion technology, which will diversify Jul 02, 2019 · In 2017, Incyte entered into an exclusive global collaboration and license agreement with MacroGenics, Inc. 5 May 2020 The PressReader Terms of Use, Privacy Policy, and this Software License Agreement (“Agreement”) are a binding (a) all of the contents of the files, disk(s ), CD-ROM(s), DVD-ROM(s), USB drives, removable disks, or other media with which this Agreement is provided, Notwithstanding the foregoing, you may not transfer education, pre-release, or not for resale copies of the Software. Press Release . ThyssenKrupp Uhde and SGCE enter into Master License and Supply Agreement. press release license agreement

0yabxtdvqngk, fdvoy js1es, 0rslt7xp2xoakjj6kxh, qawmb 6v1q8c2 u, dyv86wa5w tlq3x, urwz rerqbp,